Introduction of a national herpes zoster (shingles) immunization programme and impact on neuropathic pain

摘要

In September 2013, the United Kingdom was the first country in Europe to launch a national herpes zoster (HZ) immunization programme, following implementation in the United States in 2006. The HZ vaccine has been offered to immunocompetent adults aged 70 years, with a targeted catch-up for 79 year olds.